135 related articles for article (PubMed ID: 27921386)
1. Cytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole Carboxamides.
Spare LK; Falsetta P; Gilbert J; Harman DG; Baker MA; Li F; McCluskey A; Clegg JK; Sakoff JA; Aldrich-Wright JR; Gordon CP
ChemMedChem; 2017 Jan; 12(2):130-145. PubMed ID: 27921386
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.
Tu GG; Zhan JF; Lv QL; Wang JQ; Kuang BH; Li SH
Med Chem; 2014 Jun; 10(4):376-81. PubMed ID: 23909288
[TBL] [Abstract][Full Text] [Related]
4. Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill TA; Stewart SG; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Sep; 15(18):6126-34. PubMed ID: 17606377
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of a series of norcantharidin analogues.
Tarleton M; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2012 Aug; 54():573-81. PubMed ID: 22796041
[TBL] [Abstract][Full Text] [Related]
6. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
[TBL] [Abstract][Full Text] [Related]
7. 1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).
Penthala NR; Ketkar A; Sekhar KR; Freeman ML; Eoff RL; Balusu R; Crooks PA
Bioorg Med Chem; 2015 Nov; 23(22):7226-33. PubMed ID: 26602084
[TBL] [Abstract][Full Text] [Related]
8. Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.
Robertson MJ; Gordon CP; Gilbert J; McCluskey A; Sakoff JA
Bioorg Med Chem; 2011 Sep; 19(18):5734-41. PubMed ID: 21855357
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives.
Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK
Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
11. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
12. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety.
Sun J; Ambrus JI; Baker JR; Russell CC; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
Bioorg Med Chem Lett; 2022 Apr; 61():128591. PubMed ID: 35114371
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
[TBL] [Abstract][Full Text] [Related]
14. A facile hybrid 'flow and batch' access to substituted 3,4-dihydro-2H-benzo[b][1,4]oxazinones.
Lin AJ; Russell CC; Baker JR; Frailey SL; Sakoff JA; McCluskey A
Org Biomol Chem; 2016 Sep; 14(37):8732-8742. PubMed ID: 27714138
[TBL] [Abstract][Full Text] [Related]
15. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.
Hart ME; Chamberlin AR; Walkom C; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2004 Apr; 14(8):1969-73. PubMed ID: 15050639
[TBL] [Abstract][Full Text] [Related]
16. A focused library synthesis and cytotoxicity of quinones derived from the natural product bolinaquinone.
Ghods A; Gilbert J; Baker JR; Russell CC; Sakoff JA; McCluskey A
R Soc Open Sci; 2018 Apr; 5(4):171189. PubMed ID: 29765626
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
18. Facile Chemical Access to Biologically Active Norcantharidin Derivatives from Biomass.
Galkin KI; Kucherov FA; Markov ON; Egorova KS; Posvyatenko AV; Ananikov VP
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231880
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P
Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675
[TBL] [Abstract][Full Text] [Related]
20. trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.
Guerrero E; Miranda S; Lüttenberg S; Fröhlich N; Koenen JM; Mohr F; Cerrada E; Laguna M; Mendía A
Inorg Chem; 2013 Jun; 52(11):6635-47. PubMed ID: 23692403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
